Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Nov 3, 2017
Financial News
BioArctic prices SSE IPO
...SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie Investment Bank AB and the
DNB Markets
...
Read More
BioCentury
|
Apr 24, 2017
Clinical News
Wilson upgraded after final Phase II copper readout
...bis-choline tetrathiomolybdate (WTX101) to treat Wilson's disease, in which excess copper accumulates in the body.
DNB Markets
...
Read More
BioCentury
|
Apr 14, 2017
Financial News
BerGenBio completes IPO
...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and
DNB markets
...
Read More
BioCentury
|
Apr 6, 2017
Financial News
BerGenBio set to trade after Oslo IPO
...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and
DNB markets
...
Read More
BioCentury
|
Mar 10, 2017
Financial News
BerGenBio proposes IPO
...launch an IPO on the Oslo exchange underwritten by ABG Sundal Collier, Arctic Securities and
DNB Markets
...
Read More
BioCentury
|
Mar 8, 2017
Financial News
BerGenBio planning Oslo IPO
...said it plans to launch an IPO underwritten by ABG Sundal Collier, Arctic Securities and
DNB Markets
...
Read More
BioCentury
|
Feb 24, 2017
Financial News
Oncopeptides raises SEK650M in IPO
...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and
DNB Markets
...
Read More
BioCentury
|
Feb 24, 2017
Financial News
Oncopeptides completes IPO
...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and
DNB Markets
...
Read More
BioCentury
|
Dec 9, 2016
Financial News
Nordic Nanovector completes private placement
...$59.2 million) through the sale of 4.4 million shares at NOK114 in a private placement.
DNB Markets
...
Read More
BioCentury
|
Dec 9, 2016
Financial News
Zimmer Biomet completes private placement of senior notes
...RBC Capital Markets, Mitsubishi UFJ Financial Group, Wells Fargo, BMO Capital Markets, Citigroup, Credit Suisse,
DNB Markets
...
Read More
Items per page:
10
1 - 10 of 37
BioCentury
|
Nov 3, 2017
Financial News
BioArctic prices SSE IPO
...SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie Investment Bank AB and the
DNB Markets
...
Read More
BioCentury
|
Apr 24, 2017
Clinical News
Wilson upgraded after final Phase II copper readout
...bis-choline tetrathiomolybdate (WTX101) to treat Wilson's disease, in which excess copper accumulates in the body.
DNB Markets
...
Read More
BioCentury
|
Apr 14, 2017
Financial News
BerGenBio completes IPO
...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and
DNB markets
...
Read More
BioCentury
|
Apr 6, 2017
Financial News
BerGenBio set to trade after Oslo IPO
...million shares at NOK25 in an IPO underwritten by ABG Sundal Collier, Arctic Securities and
DNB markets
...
Read More
BioCentury
|
Mar 10, 2017
Financial News
BerGenBio proposes IPO
...launch an IPO on the Oslo exchange underwritten by ABG Sundal Collier, Arctic Securities and
DNB Markets
...
Read More
BioCentury
|
Mar 8, 2017
Financial News
BerGenBio planning Oslo IPO
...said it plans to launch an IPO underwritten by ABG Sundal Collier, Arctic Securities and
DNB Markets
...
Read More
BioCentury
|
Feb 24, 2017
Financial News
Oncopeptides raises SEK650M in IPO
...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and
DNB Markets
...
Read More
BioCentury
|
Feb 24, 2017
Financial News
Oncopeptides completes IPO
...shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and
DNB Markets
...
Read More
BioCentury
|
Dec 9, 2016
Financial News
Nordic Nanovector completes private placement
...$59.2 million) through the sale of 4.4 million shares at NOK114 in a private placement.
DNB Markets
...
Read More
BioCentury
|
Dec 9, 2016
Financial News
Zimmer Biomet completes private placement of senior notes
...RBC Capital Markets, Mitsubishi UFJ Financial Group, Wells Fargo, BMO Capital Markets, Citigroup, Credit Suisse,
DNB Markets
...
Read More
Items per page:
10
1 - 10 of 37
Previous page
Next page